Analysis of the Role of the Microbiota in Diverticular Disease

N/ANot Yet RecruitingNCT07681505

Hospital of Navarra285 enrolled

Overview

A single-center, prospective observational cohort study conducted at the University Hospital of Navarra. The primary objective is to expand knowledge of diverticular disease and its pathological variants, as well as the influence of the microbiota in our environment, both clinically and molecularly; to describe the clinical and pathological characteristics of patients with diverticulosis and acute diverticulitis; to analyze any differences in the microbiota; and to identify the risk factors and groups associated with diverticular disease in order to establish the best strategies for prevention and treatment.

Study Type

OBSERVATIONAL

Enrollment

285

Conditions

Diverticular Disease of Colon Acute Diverticulitis Gut Microbiota

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age 18 or older. * Signing of the informed consent form. * Assignment to one of the study groups mentioned above. Exclusion Criteria: * An episode of acute diverticulitis located in the right colon or transverse colon. * Antibiotic treatment within the six weeks prior to the episode (except for antibiotics started in the emergency department or within 24 hours prior to sample collection). * Mechanical bowel preparation within the three weeks prior to sample collection. * Diagnosis of colorectal cancer. * Diagnosis of inflammatory bowel disease. * Failure to sign the informed consent form.

Outcomes

Primary Outcomes

To investigate the microbiota influences the development of diverticulosis

To investigate whether the microbiota influences the development of diverticulosis and a first episode of acute diverticulitis.

Time frame: From the diagnosis until two years

Secondary Outcomes

To investigate how the microbiota affects the therapeutic response in patients presenting with a first episode of acute diverticulitis.

Time frame: From the diagnosis until 8 weeks

To investigate how the microbiota is affected in patients treated with anti-inflammatory drugs versus antibiotic therapy.